Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple sexually transmitted infections from a single sample. | The company’s cobas ...
SCHD said that the partnership will allow expanded clinical services, enabling the health department to provide HIF and ...
HIV, the incurable virus that can lead to AIDS if not treated, is most prevalent in Georgia, with 23.1 cases per 100,000 ...
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...
The cobas liat test aims to improve patient outcomes by offering rapid, accurate results in decentralized and community-based ...
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...
Some places carry a higher risk of sexually transmitted diseases — where ... In Alaska, rates of gonorrhea infection are 251.1 per 100,000 people, while rates of chlamydia are 700.9 per 100,000 ...
The World Health Organization (WHO) recently released new estimates suggesting around 846 million people aged between 15 and ...
Flare-ups of herpes occur when the virus becomes active after being dormant. Triggers for these outbreaks can include stress, ...
Newly-released health data shows a huge rise in cases of syphillis in the North East between 2022 and 2023. The region saw a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback